Kezar Life Sciences, INC. (KZR) — 10-Q Filings

10-Q Filings (6)

• Kezar Narrows Q3 Loss Amid Strategic Review, 70% Workforce Cut — Nov 12, 2025 Risk: high
  Kezar Life Sciences, Inc. (KZR) reported a net loss of $11.2 million for the three months ended September 30, 2025, a significant improvement from the $20.3 mil
• Kezar Narrows Q2 Loss on Reduced R&D Spending — Aug 13, 2025 Risk: high
  Kezar Life Sciences, Inc. (KZR) reported a net loss of $13.7 million for the three months ended June 30, 2025, a significant improvement from the $21.5 million
• Kezar Life Sciences Q1 2025 Financial Update — May 13, 2025 Risk: low
  Kezar Life Sciences, Inc. filed its quarterly report for the period ending March 31, 2025. The company's financial statements show changes in common stock, addi
• Kezar Life Sciences Q3 2024 Update — Nov 12, 2024 Risk: medium
  Kezar Life Sciences, Inc. filed its 10-Q for the period ending September 30, 2024. The company reported on its financial condition and results of operations, in
• Kezar Life Sciences Files Q2 2024 10-Q — Aug 13, 2024 Risk: medium
  Kezar Life Sciences, Inc. filed its 10-Q for the period ending June 30, 2024. The company reported on its financial condition and results of operations, includi
• Kezar Life Sciences Files 10-Q for Period Ending March 31, 2024 — May 9, 2024 Risk: medium
  Kezar Life Sciences, Inc. (KZR) filed a Quarterly Report (10-Q) with the SEC on May 9, 2024. Kezar Life Sciences, Inc. filed a 10-Q report for the period ending

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX